Pascual Sanz
Affiliations: | Instituto de Biomedicina de Valencia, València, Comunidad Valenciana, Spain |
Google:
"Pascual Sanz"Mean distance: (not calculated yet)
Parents
Sign in to add mentorEnrique Herrero Perpiñán | grad student | University of Valencia, Spain | |
Rafael Sentandreu Ramón | grad student | University of Valencia, Spain | |
Marian Carlson | post-doc | (Microtree) | |
David Meyer | post-doc |
Children
Sign in to add traineeTeresa Rubio | grad student | IDIBELL | |
Carla Rubio-Villena | grad student | European University of Madrid | |
Carmen Munoz-Ballester | grad student | 2012-2017 | Instituto de Biomedicina de Valencia |
Carlos Romá Mateo | post-doc | University of Valencia, Spain | |
Eva Pérez-Jiménez | post-doc | Instituto de Biomedicina de Valencia | |
Santiago Vernia | post-doc | MRC Clinical Sciences Center, Imperial College | |
Rosa Viana | post-doc | Instituto de Biomedicina de Valencia | |
Maria Adelaida García-Gimeno | research scientist | Universidad Politécnica de Valencia |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sanz P, Rubio T, Garcia-Gimeno MA. (2024) Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs. International Journal of Molecular Sciences. 25 |
Rubio T, Campos-Rodríguez Á, Sanz P. (2023) Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes. Molecular Neurobiology |
Moreno-Estellés M, Campos-Rodríguez Á, Rubio-Villena C, et al. (2023) Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model. International Journal of Molecular Sciences. 24 |
Rubio T, Viana R, Moreno-Estellés M, et al. (2022) TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy. Neurobiology of Disease. 176: 105964 |
Vela M, García-Gimeno MA, Sanchis A, et al. (2021) Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington Disease. Acs Chemical Neuroscience |
Brewer MK, Machio-Castello M, Viana R, et al. (2021) An empirical pipeline for personalized diagnosis of Lafora disease mutations. Iscience. 24: 103276 |
Kumarasinghe L, Xiong L, Garcia-Gimeno MA, et al. (2021) TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases. Cells. 10 |
Perez-Jimenez E, Viana R, Muñoz-Ballester C, et al. (2020) Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease. Glia |
Sanz P, Garcia-Gimeno MA. (2020) Reactive Glia Inflammatory Signaling Pathways and Epilepsy. International Journal of Molecular Sciences. 21 |
Espinós C, Galindo MI, García-Gimeno MA, et al. (2020) Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration. Antioxidants (Basel, Switzerland). 9 |